Publication date: Mar 22, 2025
The effect of alcohol consumption on COVID-19 vaccine immunogenicity was evaluated. Participants from the Stop the Spread Ottawa cohort were categorized by alcohol consumption categorized as excessive or non-excessive based on the Canadian Centre on Substance Abuse and Addiction’s (CCSA) 2023 guidelines on alcohol use. Our analyses showed that alcohol consumption did not influence SARS-CoV-2 antibody baseline levels, post vaccine increase or decay over time.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Alcohol | Alcohol |
| Canadian | COVID-19 vaccines |
| Covid | SARS-CoV-2 |
| Stop | Vaccine immunogenicity |
| Vaccine |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Ethanol |
| disease | MESH | Substance Abuse |
| disease | MESH | Infectious Diseases |
| disease | MESH | Infection |
| disease | MESH | Inflammation |
| disease | MESH | COVID 19 |
| disease | MESH | breakthrough infections |
| disease | IDO | production |
| disease | MESH | obesity |
| disease | MESH | morbidities |
| disease | MESH | reinfection |
| disease | IDO | blood |
| disease | IDO | cell |
| disease | IDO | assay |
| drug | DRUGBANK | Coenzyme M |
| disease | IDO | history |
| drug | DRUGBANK | Methionine |
| disease | MESH | allergies |
| disease | MESH | hypertension |
| disease | MESH | dyslipidemia |
| disease | IDO | immunosuppression |
| pathway | KEGG | Primary immunodeficiency |
| disease | IDO | primary immunodeficiency |
| disease | MESH | autoimmune disease |
| disease | MESH | cancer |
| disease | MESH | asthma |
| pathway | KEGG | Asthma |
| drug | DRUGBANK | Hyaluronic acid |
| drug | DRUGBANK | Tretamine |
| pathway | REACTOME | Immune System |
| disease | MESH | alcoholic hepatitis |
| disease | MESH | abnormalities |
| disease | MESH | lung injury |
| disease | MESH | hepatitis |
| disease | IDO | susceptibility |
| disease | MESH | common cold |
| disease | MESH | arthritis |
(Visited 2 times, 1 visits today)